CAS: 2624131-45-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1-(6-(3-fluoro-5-(trifluoromethyl)benzyl)pyrimidin-4-yl)-N-(2-hydroxyethyl)indoline-4-carboxamide REF: IN-DA01KGBICAS: 2624131-45-7 | % | 143,00 €~2.817,00 € | Jue 27 Mar 25 |
 | PW0787 REF: TM-T9452CAS: 2624131-45-7 | 98.42% | 37,00 €~690,00 € | Jue 03 Abr 25 |
 | 1-(6-{[3-Fluoro-5-(trifluoromethyl)phenyl]methyl}pyrimidin-4-yl)-N-(2-hydroxyethyl)-2,3-dihydro-1H-indole-4-carboxamide REF: 3D-ZEE13145CAS: 2624131-45-7 | Min. 95% | - - - | Producto descatalogado |
1-(6-(3-fluoro-5-(trifluoromethyl)benzyl)pyrimidin-4-yl)-N-(2-hydroxyethyl)indoline-4-carboxamide
CAS:2624131-45-7
Fórmula:
C23H20F4N4O2
Pureza:
%
Forma y color:
Solid
Peso molecular:
460.4241
Ref: IN-DA01KGBI
| 50mg | 307,00 € |
Entrega estimada en Estados Unidos, el Jueves 27 de Marzo de 2025
PW0787
CAS:2624131-45-7
PW0787 is a potent, selective, orally active, and brain-penetrant GPR52 agonist (EC50=135 nM).
Fórmula:
C23H20F4N4O2
Pureza:
98.42%
Forma y color:
Solid
Peso molecular:
460.42
Ref: TM-T9452
| 1mg | 37,00 € | ||
| 5mg | 80,00 € | ||
| 10mg | 117,00 € | ||
| 25mg | 235,00 € | ||
| 50mg | 353,00 € | ||
| 100mg | 500,00 € | ||
| 200mg | 690,00 € | ||
| 1mL*10mM (DMSO) | 96,00 € |
Entrega estimada en Estados Unidos, el Jueves 3 de Abril de 2025
![1-(6-{[3-Fluoro-5-(trifluoromethyl)phenyl]methyl}pyrimidin-4-yl)-N-(2-hydroxyethyl)-2,3-dihydro-...](https://static.cymitquimica.com/products/3D/thumb/ZEE13145.jpg)
1-(6-{[3-Fluoro-5-(trifluoromethyl)phenyl]methyl}pyrimidin-4-yl)-N-(2-hydroxyethyl)-2,3-dihydro-1H-indole-4-carboxamide
CAS:2624131-45-7
Please enquire for more information about 1-(6-{[3-Fluoro-5-(trifluoromethyl)phenyl]methyl}pyrimidin-4-yl)-N-(2-hydroxyethyl)-2,3-dihydro-1H-indole-4-carboxamide including the price, delivery time and more detailed …
Fórmula:
C23H20F4N4O2
Pureza:
Min. 95%
Peso molecular:
460.4 g/mol
Ref: 3D-ZEE13145
| 5mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información |
